![Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it](/docs/US/2019-04-02/US10245270B2/abs.jpg.600x600.jpg)
- Patent Title: Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it
-
Application No.: US16120797Application Date: 2018-09-04
-
Publication No.: US10245270B2Publication Date: 2019-04-02
- Inventor: Alexandre Le Flohic , Jérôme Guidotti , Philippe Letellier
- Applicant: LES LABORATOIRES SERVIER
- Applicant Address: FR Suresnes
- Assignee: LES LABORATOIRES SERVIER
- Current Assignee: LES LABORATOIRES SERVIER
- Current Assignee Address: FR Suresnes
- Agency: Hueschen and Sage
- Priority: FR1356870 20130712
- Main IPC: C07D417/14
- IPC: C07D417/14 ; A61K31/5377 ; A61K45/06
![Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it](/abs-image/US/2019/04/02/US10245270B2/abs.jpg.150x150.jpg)
Abstract:
3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione methanesulphonate of formula (II): Medicinal products containing the same which are useful in treating cancer.
Public/Granted literature
Information query
